IEEE Spectrum on MSN
AlphaGenome deciphers non-coding DNA for gene regulation
Deep-learning model decodes the regulatory effects of DNA changes ...
Researchers have revealed that so-called ‘junk DNA’ contains powerful switches that help control brain cells linked to Alzheimer’s disease. When people picture DNA, they often imagine a set of genes ...
Non-coding DNA variants contribute to acute lymphoblastic leukemia (ALL) chemotherapy resistance. St. Jude Children's Research Hospital scientists have identified specific DNA variants in the ...
Fixing gene defects with designer DNA is on the horizon after Google DeepMind launched a pioneering new AI tool.
Morning Overview on MSN
AlphaGenome cracks the dark DNA code controlling gene switches
For decades, biologists have known that the instructions for life are written in DNA, yet the vast majority of those letters seemed to sit in the dark, doing little that was obvious. Now a new ...
Once disregarded as “junk DNA,” scientists now know that this molecular dark matter is crucial for determining gene activity ...
Artificial intelligence has gotten a bad reputation lately, and often for good reason. But a team of scientists at Google’s ...
The non-coding genome, once dismissed as "junk DNA", is now recognized as a fundamental regulator of gene expression and a key player in understanding complex diseases. Following the landmark ...
Researchers have developed a method to swiftly screen the non-coding DNA of the human genome for links to diseases that are driven by changes in gene regulation. The technique could revolutionize ...
The human genome contains about 20,000 protein-coding genes, but that only accounts for roughly two percent of the genome. For many years, it was easier for scientists to simply ignore all of that ...
Much of the "junk" DNA in Drosophila shows signs of either negative or positive selection, according to a study in this week's Nature. An analysis by Peter Andolfatto of the University of California, ...
(L to R) Co-first author Jackson Mobley, PhD, corresponding author Daniel Savic, PhD, and co-first author Kashi Raj Bhattarai, PhD, all of the St. Jude Department of Pharmacy and Pharmaceutical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results